Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture
- PMID: 1722324
- PMCID: PMC53110
- DOI: 10.1073/pnas.88.24.11241
Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture
Abstract
We have recently described a nonnucleoside compound that specifically inhibits the reverse transcriptase of human immunodeficiency virus type 1 (HIV-1), the causative agent of AIDS. This compound, nevirapine (BI-RG-587), interacts with highly conserved tyrosine residues at positions 181 and 188 in the reverse transcriptase to inhibit the recombinant enzyme and virus replication in cell culture with 50% inhibitory concentrations in the 40 nM range. HIV-1 variants resistant to nevirapine emerged with passage in cell culture in the presence of drug. This resistant phenotype was stable with continued passage in the absence of drug. These mutants had a substitution of cysteine for the tyrosine at position 181. Introduction of this mutation into the recombinant enzyme increased the inhibitory concentration of nevirapine 100-fold. Substitution of cysteine for tyrosine at residue 181 into the wild-type viral genome conferred a similar reduction in susceptibility to nevirapine. Mutants were also resistant to a tetrahydroimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one and -thione derivative and two 6-phenylthiouracil derivatives but retained their sensitivity to the other reverse transcriptase inhibitors, 3'-azido-3'-deoxythymidine and foscarnet.
Similar articles
-
In vitro selection and molecular characterization of human immunodeficiency virus-1 resistant to non-nucleoside inhibitors of reverse transcriptase.Mol Pharmacol. 1992 Mar;41(3):446-51. Mol Pharmacol. 1992. PMID: 1372083
-
Chimeric human immunodeficiency virus type 1/type 2 reverse transcriptases display reversed sensitivity to nonnucleoside analog inhibitors.Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9878-82. doi: 10.1073/pnas.88.21.9878. Proc Natl Acad Sci U S A. 1991. PMID: 1719542 Free PMC article.
-
Functional analysis of HIV-1 reverse transcriptase amino acids involved in resistance to multiple nonnucleoside inhibitors.J Biol Chem. 1992 Sep 5;267(25):17526-30. J Biol Chem. 1992. PMID: 1381350
-
The genetic and functional basis of HIV-1 resistance to nonnucleoside reverse transcriptase inhibitors.Arch Virol Suppl. 1994;9:11-7. doi: 10.1007/978-3-7091-9326-6_2. Arch Virol Suppl. 1994. PMID: 7518271 Review.
-
Inhibition of HIV-1 reverse transcriptase and virus replication by a non-nucleoside dipyridodiazepinone BI-RG-587 (Nevirapine).Med Res Rev. 1992 Jan;12(1):27-40. doi: 10.1002/med.2610120103. Med Res Rev. 1992. PMID: 1371177 Review. No abstract available.
Cited by
-
HIV-1 Env C2-V4 diversification in a slow-progressor infant reveals a flat but rugged fitness landscape.PLoS One. 2013 Apr 29;8(4):e63094. doi: 10.1371/journal.pone.0063094. Print 2013. PLoS One. 2013. PMID: 23638182 Free PMC article.
-
Pharmacokinetics of R 82913 in AIDS patients: a phase I dose-finding study of oral administration compared with intravenous infusion.Antimicrob Agents Chemother. 1992 Dec;36(12):2661-3. doi: 10.1128/AAC.36.12.2661. Antimicrob Agents Chemother. 1992. PMID: 1482134 Free PMC article. Clinical Trial.
-
Reversion of the M184V mutation in simian immunodeficiency virus reverse transcriptase is selected by tenofovir, even in the presence of lamivudine.J Virol. 2003 Jan;77(2):1120-30. doi: 10.1128/jvi.77.2.1120-1130.2003. J Virol. 2003. PMID: 12502828 Free PMC article.
-
R88-APOBEC3Gm Inhibits the Replication of Both Drug-resistant Strains of HIV-1 and Viruses Produced From Latently Infected Cells.Mol Ther Nucleic Acids. 2014 Mar 4;3(3):e151. doi: 10.1038/mtna.2014.2. Mol Ther Nucleic Acids. 2014. PMID: 24594845 Free PMC article.
-
Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy.J Virol. 1994 Mar;68(3):1660-6. doi: 10.1128/JVI.68.3.1660-1666.1994. J Virol. 1994. PMID: 7509000 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases